Lectin binding patterns of human tissue mast cells indicate marked phenotypical diversity.
Glycoconjugate expression by human tissue mast cells (MCs) from various sources (including lymph nodes with signs of chronic non-specific lymphadenitis, skin lesions of urticaria pigmentosa, and bone marrow infiltrates associated with systemic mastocytosis) was studied histochemically with a broad panel of fluorescein-labelled lectins. Of the 19 lectins applied, 11 (sugar specificities: fucose, N-acetylgalactosamine and neuraminic acid) did not stain any MCs, while 8 (sugar specificities: mannose, N-acetylglucosamine, and galactose) were found to bind to MCs. These lectins exhibited different binding patterns in various disease entities. Only a few of these 8 lectins (in particular, phythaemagglutinin-L) produced strong staining of the MCs in most or all of the cases. Some (e. g. phythemagglutinin-E) produced only weak staining, and this in only a few cases. The lectins used, however, did not distinguish between reactive and tumorous MCs. Although lectins are therefore unlikely to be of use in resolving problems of differential diagnosis concerning proliferation of MCs, our investigation has shown that tissue MCs exhibit marked phenotypical diversity with regard to their lectin-binding properties.
Schumacher
U
U
Human Morphology, University of Southampton, UK.
Horny
H P
HP
Welsch
U
U
Geerts
M L
ML
Kaiserling
E
E
D001706:Biopsy; D001853:Bone Marrow / Q000473:pathology; D006001:Glycoconjugates / Q000032:analysis*; D006801:Humans; D037102:Lectins; D008198:Lymph Nodes / Q000473:pathology; D008199:Lymphadenitis / Q000473:pathology; D008407:Mast Cells / Q000473:pathology*; D008415:Mastocytosis / Q000473:pathology; D009442:Neurilemmoma / Q000473:pathology; D010641:Phenotype; D012878:Skin Neoplasms / Q000473:pathology; D014581:Urticaria / Q000473:pathology
D006001:Glycoconjugates; D037102:Lectins